Match Document Document Title
DE3912046B4 A method for marking a component of an aqueous liquid and lumineszenzphotostabiles reaction product  
A method of labeling a component of an aqueous liquid, characterized in that (a) to which said component-containing liquid has a luminescence dye from the group of cyanine, merocyanine and styryl...
DE10262005A1 Foodstuff or pharmaceutical compositions containing hydrogenated condensed palatinose, useful e.g. as sweetener or soluble dietary fiber source and/or for combating intestinal inflammation or cancer  
Foodstuffs, sweeteners or pharmaceutical compositions containing hydrogenated condensed palatinose (I) are new. Foodstuffs, sweeteners or pharmaceutical compositions containing hydrogenated...
DE10242433A1 Chip carrying probes for specific genes, useful for rapid monitoring of organism status, particularly during fermentation  
Chip (A) that carries probes (I) for at least one of 34 specified genes, or from similarly regulated genes involved in the corresponding metabolic pathways in other organisms. Chip (A) that...
DE10242062B4 Hydrogenated condensed palatinose, processes for their preparation and their use  
process for the production of hydrogenated condensed Palatinose comprising containing the catalytic hydrogenation of a condensed Palatinose aqueous solution at an elevated Temperature of 40 ° C to...
DE10242062A1 New hydrogenated condensed palatinose products, useful in food, feed or medicament compositions, e.g. for combating diabetes or cancer, obtained by catalytic hydrogenation of condensed palatinose solution  
Production of hydrogenated condensed palatinose (I) involves catalytic hydrogenation of a solution containing a condensed palatinose (II). Independent claims are included for: (1) (I) obtained by...
DE10241938A1 Selecting specific-bonding nucleic acid, by a modified SELEX process that includes purification by ultrafiltration to facilitate automation  
Selecting, from a mixture of candidates, at least one nucleic acid (NA) that is a ligand able to bind a target molecule (TM), is new. Selecting, from a mixture of candidates, at least one nucleic...
DE10241208B4 Presbyopiekorrigierende contact lens and methods of manufacture for such a contact lens  
Presbyopiekorrigierende Contact lens (1, 20, 30, 60) with at least one near-vision zone (8, 21, 32, 66) with high refractive power and at least one far vision zone (9, 22, 33, 65) with a lower...
DE10111682B4 Caloporoside derivatives, processes for their preparation and their use  
Compounds of formula I in which: R1, R2, R3, Independently of one another H or acyl radicals having 1 to 10 carbon atoms; and R4 Is H or -C (O) (CH2)nCOOH, wherein n is 1 to 7; except that R1, R2,...
DE10244057A1 Use of nucleic acid for detecting explosives, by specific binding interaction, also new aptamers for the process and test device  
Use of a nucleic acid (I) for detecting an explosive (II). (I) binds specifically to at least part of the molecular structure of (II) and this binding is detected. Independent claims are also...
DE10241152A1 Tubulysin biosynthesis genes  
ssDNA molecule selected from the group consisting of: (i) an ssDNA molecule according to a sequence1; (Ii) an ssDNA molecule with a ss-DNA-molecule according to (i) with respect to its nucleotide...
DE10241116A1 Process for the recovery of uridine from molasses  
The present invention relates to a process for the recovery of uridine from molasses by chromatographic method, said enriched uridine and obtained in high yield and high purity, and in particular...
DE10255104A1 Methods and nucleic acids for the analysis of breast cell proliferative disorders  
The present invention relates to modified and genomic sequences, oligonucleotides and / or PNA-oligomers for detecting the cytosine methylation state of genomic DNA, and a method for ascertaining...
DE10240417A1 Decoy oligonucleotide inhibition of CD40 expression  
The present invention relates to decoy oligonucleotides with the nucleic acid sequence according to SEQ ID NO: 1 to 36 and their use as medicaments.
DE10237704A1 Method and apparatus for intermolecular transfer of activation energy for bond cleavage through space  
The present invention relates to a method for the cleavage of chemical bonds, whereby the activation energy is supplied to the bond cleavage through the space from a carrier molecule that can move...
DE10237393A1 Determining risk of developing arteriosclerosis or coronary artery disease, by detecting both polymorphisms in the mbl2 gene and infection by Chlamydia pneumoniae  
Method for determining an indicator of the risk of developing arteriosclerosis and severe heart disease of the coronary artery type by detecting both: (a) polymorphisms in the human mbl2 gene; and...
DE10240923A1 Flavonoid derivatives for eczema treatment  
It is the use of certain flavonoid derivatives for the preparation of formulations described suitable for the prophylaxis and / or therapy of eczema. In particular, the preparations are suitable...
DE10238978A1 Method for preparing ketocarotenoids, useful e.g. as food or feed supplements, by increasing, or introducing, ketolase activity in the fruits of transgenic plants, also new nucleic acid constructs  
Method for preparing ketocarotenoids (I) by culturing genetically modified plants that, in comparison with the wild-type, have altered ketolase (II) activity in the fruits. Independent claims are...
DE10238922A1 Immune markers for diagnosis and treatment in connection with graft-reactions  
The invention relates to immune markers for the detection of inflammation, immune responses, and in particular of graft tolerances or graft reactions, a method for the detection of graft reactions...
DE10237691B4 A method for detecting single nucleotide polymorphisms (SNP) in genes of drug metabolism and test kit for performing the method  
A method for the detection of single nucleotide polymorphisms in the cytochrome P450 genes, characterized in that a) gene segments of human CYP2 genes from a sample with the amplification primers...
DE10235988A1 New mutant nucleic acid encoding the human MSH3 protein, useful e.g. for diagnosis and treatment of neoplasia, also for drug discovery  
Nucleic acid (I), or fragment of it, that encodes the human mismatch repair gene MSH3 protein and has a sequence that differs from the reference sequence by mutation at at least one specific...
DE10141464A1 New nucleic acid representing a polymorphism in the 22444 gene, useful for diagnosis and treatment of neuropsychiatric diseases and in drug screening  
Nucleic acid (DNA) (I) comprising at least 10 nucleotides (nt) that represent a polymorphic fragment of the reference sequence of the 22444 gene (sequence of 10500 nt reproduced) or its...
DE20215415U1 Water-soluble prodrugs of propofol  
A Verbinung having the formula: wherein R1 is a cyclic or linear amino acid and the diastereomers or enantiomers in the form of their bases or salts and wherein the amino acid is optionally...
DE10237517B4 A process for the enrichment or depletion of biomolecules from liquid or fluid media using Schichtdoppelhydroxiden and use of other on a layered double hydroxide or incorporated biomolecules as inorganic Vector  
A process for the removal or recovery or purification of at least one biomolecule, which contains, as building blocks nucleotides, nucleosides, amino acids, monosaccharides and / or fatty acids...
DE10237517A1 Removing biomolecules from liquid media, useful for purification, product recovery or preparation of vectors, comprises retention on hydrotalcite of controlled porosity  
Removing at least one biomolecule (I) from a liquid or fluid medium using as absorption agent a double layered hydroxide (II), i.e. natural or synthetic hydrotalcite or similar compounds, where...
DE10237412A1 Production of sulfated alcohols, useful as mild anionic surfactants in detergents or cosmetics, involves reaction of alcohols with acid sulfation products capable of transferring acid sulfate groups to the alcohol  
Production of sulfated alcohols by reacting an alcohol or alcohol mixture with an acid sulfation product of an alcohol (carrier) or mixture of such sulfation products is such that under the...
DE10237073A1 Determining genetic disposition to thrombosis, by testing for presence of at least two allelic polymorphisms associated with increased risk, followed by multifactorial analysis of the results  
Determining the genetic predisposition of a subject for development of thrombosis comprises examining at least 2 nucleic acid segments (A) from the genome, followed by multifactorial analysis of...
DE10236034A1 New labeling material, useful in marking products for protection against counterfeiting, comprises nucleic acid encapsulated in soluble or meltable packaging  
A labeling substance (A) comprises (a) one or more polymeric nucleic acids, or their analogs, (I) as data carriers and (b) a molecular packaging, made of a hardenable mass that can be re-melted at...
DE10233970A1 Multi-well filtration plate, for high throughput applications in the automatic isolation of DNA and RNA, has a nonwoven support at the filter membrane to stabilize it and prevent damage  
The multi-well filtration plate is stabilized by a support material (4) at the filter membrane (3), using a glass fiber or polymer nonwoven. The nonwoven is a commercially available material with...
DE10232621A1 For an enzyme delta-12 desaturase-encoding nucleic acid sequence associated polypeptide and use of both  
Enzymes from the group of delta 12 desaturases catalyze an important step for the synthesis of essential human polyunsaturated fatty acids, which serve all eukaryotes as important structural...
DE10230692A1 Methods and nucleic acids for the analysis of methylation patterns within the DD3 gene  
The present invention provides methods and sequences for analysis of methylation patterns within the 5 'and promoter regions of the gene DD3 available.
DE10234126A1 A process for the biotransformation of carotenoids  
The invention relates to a method for the biotransformation of carotenoids using enzymes with cytochrome P450 monooxygenase activity; in particular monooxygenases from thermophilic bacteria,...
DE10232774A1 Cosmetic preparations with antibacterial properties  
invention relates to cosmetic preparations which are characterized in that they contain an effective amount of glycyrrhetic acid and derivatives thereof.
DE10232595A1 Light stabilizers  
The invention relates to a preparation having light-protection properties, comprising at least one compound of formula I where R1 and R2 are selected from H and OR11Wherein OR11 is independently...
DE10231659A1 Composition for binding nucleic acid to a solid phase  
The present invention relates to a composition for binding nucleic acids in aqueous solution to a solid phase containing a guanidinium salt, a buffer substance and a detergent, characterized in...
DE10231370A1 Thiophenglycosidderivate new, processes for their preparation, pharmaceutical compositions containing them and their use  
The invention relates to novel Thiophenglycosidderivate of the formula I, wherein the radicals have the meanings time shown, and their physiologically acceptable salts and processes for their...
DE10231297A1 Nucleotide sequences of coryneform bacteria coding for participating in the biosynthesis of L-serine proteins and methods for producing L-serine  
The invention relates to nucleotide sequences of coryneform bacteria coding for participating in the biosynthesis of L-serine proteins, as well as methods for producing L-serine. By deletion of at...
DE10229391A1 Biochip, useful for identifying metastatizing tumors and assessing metastatic potential, carries cDNA copies of genes with metastasis-specific expression and of control genes  
Biochip comprises, arranged on a carrier: (a) cDNA copies (1) of genes, or their fragments, for which expression is altered in metastasis; and (b) as controls, cDNA copies (2) of genes, or their...
DE20315159U1 Kit for diagnostic detection of severe acute respiratory syndrome-associated virus, comprises primers and probes for a real-time reverse transcription polymerase chain reaction  
Kit for detecting the severe acute respiratory syndrome (SARS)-associated virus (human pneumonia-associated coronavirus; HPAC) by real-time reverse transcription-PCR (RT-PCR). Kit for detecting...
DE19705664B4 A process for producing 1,1-GPM-enriched phase with more than 75 wt .-% solid phase content to 99 wt .-% solid phase content of 1,1-GPM and 1,6-GPS-enriched phase with more than 80 wt .-% solid phase content to about 99 wt .-% solid phase content of 1,6 GPS  
A process for producing 1,1-GPM-enriched phases with more than 75 wt .-% solid phase content to about 99 wt .-% solid phase content of 1,1-GPM and 1,6-GPS-enriched phase with more than 80 percent....
DE10232139A1 With nucleic acids and nucleic acid derivatives of coated metallic object, process for its preparation and its use  
A metallic article having a metal oxide layer and an anodic polarization stable enshrined therein nucleic acid coating. The coating may be adjusted by hybridization of complementary strands and to...
DE10228857A1 Tetraether lipids with small head groups, their preparation and use  
Tetraether are bipolar Amiphile, originally isolated from natural bacteria. They are used for spherical vesicles, pharmaceutical formulations, among others, but are derived from thermophilic...
DE20121978U1 Novel chemically modified genomic DNA sequences, useful in the characterization, classification, differentiation, grading, staging, treatment and/or diagnosis of astrocytomas or predisposition to astrocytomas  
A nucleic acid (I) comprising a sequence of at least 18 bases in length of a segment of chemically pretreated genomic DNA which has any one of the sequences of (S1)-(S120) or its complement, is...
DE20121975U1 Oligonucleotide for diagnosing and treating tumors and cancer especially gliomas, astrocytomas and oligodendromas, comprises chemically modified genomic sequences of genes associated with tumors and cancers  
A nucleic acid (I) comprising a sequence of at least 18 bases of a segment of chemically pretreated genomic DNA (II) according to one of the sequences (S1) selected from 120 sequences, and its...
DE20121964U1 New nucleic acid, useful for diagnosis and therapy of metabolic disease, solid tumor and cancers, comprises segment of chemically modified genomic sequences of genes associated with metabolism  
A nucleic acid (I) comprising a sequence at least 18 bases of a segment of the chemically pretreated DNA of genes associated with metabolism such as DUSP2 (NM 004418), EPHX2 (NM 001979), QDPR (NM...
DE20121960U1 New nucleic acid derived from chemically treated metastasis genes, useful for diagnosis of cancers by analysis of cytosine methylation, also for treatment  
Nucleic acid (I) comprising at least 18 bases from a segment of the chemically pretreated DNA (A) of genes associated with metastasis, i.e. any of 198 sequences referred to but not reproduced or...
DE10229978A1 Preparation of conjugated polyunsaturated fatty acids, useful in nutrition, cosmetics and pharmaceuticals, comprises expressing specific isomerases in eukaryotic, particularly plant, cells  
Preparation of conjugated polyunsaturated fatty acids (I), having at least two double bonds, in transgenic eukaryotic organisms comprises expressing a specific nucleic acid (II) in an organism...
DE10228785A1 Detection of toxic algae  
The invention relates to sequence-specific capture probes for the detection of toxic algae by selective hybridization of a complementary, to be detected alga clearly characterizing the nucleic...
DE10228785B4 Detection of toxic algae  
oligonucleotide characterized in that one of the sequences SEQ ID No.1 to 19 exhibits.
DE10227432A1 A process for the separation of carbohydrate carboxylic acids  
The present invention relates to a method for the separation of carboxylic acids from their carbohydrate mixture by an at least single-stage reactive extraction with an extractant system...
DE10227814A1 A process for the elimination of labile funtionellen groups of chemical compounds  
The present invention provides a method for cleavage of labile functional groups from molecules by the action of electromagnetic radiation is available, wherein the molecules are brought together...